US 11452721
Formulations of pimavanserin
granted A61KA61K31/4468A61K47/38
Quick answer
US patent 11452721 (Formulations of pimavanserin) held by ACADIA Pharmaceuticals Inc. expires Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ACADIA Pharmaceuticals Inc.
- Grant date
- Tue Sep 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/4468, A61K47/38, A61K9/1652, A61K9/1688